i&i Biotech Fund is a Luxembourg-based venture capital firm investing in early-stage life sciences, biotechnology and medtech startups addressing unmet medical needs, with a primary focus on Central and Eastern Europe and broader Europe. It has acted as a lead investor and has supported investment activity in the United States. The fund enters from pre-seed and early-stage rounds, with initial checks starting at €150k and an investment range up to €2M.